Replies to post #117756 on Biotech Values

[genisi]

Cubist Announces Positive Results from Two Phase 2 Trials, CXA-201 and CDAD (C. difficile-associated diarrhea) Program

http://finance.yahoo.com/news/Cubist-Announces-Positive-bw-775770410.html?x=0&.v=1